Table 3.
Baseline | LBNP | Δ (LBNP-Baseline) | ||||||
---|---|---|---|---|---|---|---|---|
Control (n=56) |
CFS (n=14) |
p- value* |
Control (n=56) |
CFS (n=14) |
Control (n=56) |
CFS (n=14) |
p- value* |
|
Variance (mmHg2) |
37.2 (32.3–43.7) |
41.7 (25.1–63.4) |
0.509 |
35.0 (27.8–40.7) |
38.0 (33.9–47.6) |
−1.2 (−6.1–3.2) |
1.5 (−12.3–10.3) |
0.883 |
Total Power (mmHg2) |
48.4 (41.5–60.8) |
51.1 (41.5–81.6) |
0.472 |
40.2 (34.3–43.3) |
43.0 (32.2–54.2) |
−2.4 (−18.1–1.2) |
−10.2 (−46.2–6.1) |
0.481 |
HF absolute units (mmHg2) |
1.03 (0.89–1.25) |
0.71 (0.33–1.22) |
0.012 |
0.92 (0.77–1.19) |
0.68 (0.43–0.93) |
−0.14 (−0.27–−0.02) |
0.02 (−0.40–0.32) |
0.780 |
LF absolute units (mmHg2) |
5.76 (4.44–6.95) |
2.96 (1.87–8.58) |
0.223 |
6.00 (5.11–8.74) |
6.66 (3.98–11.52) |
−0.04 (−1.73–1.83) |
2.97 (−0.56–4.48) |
0.186 |
HF normalized units (nu) |
0.19 (0.15–0.25) |
0.13 (0.07–0.49) |
0.325 |
0.14 (0.10–0.21) |
0.09 (0.08–0.14) |
−0.03 (−0.07–0.03) |
−0.03 (−0.09–0.02) |
0.370 |
LF normalized units (nu) |
0.81 (0.75–0.85) |
0.87 (0.51–0.93) |
0.325 |
0.86 (0.79–0.90) |
0.91 (0.86–0.92) |
0.03 (−0.03–0.07) |
0.03 (−0.02–0.09) |
0.370 |
LF/HF | 6.24 (4.37–8.23) |
8.23 (1.34–15.38) |
0.528 | 7.64 (4.61–10.33) |
12.21 (7.84–20.40) |
−0.03 (−1.42–3.24) |
2.52 (−1.53–8.68) |
0.386 |
Wilcoxon-Mann-Whitney’s test. In order to reduce the methodological problem of multiple comparisons, statistical tests were only performed for the cardiovascular variable baseline and Δ (LBNP-Baseline)